INS and metabolic dysfunction-associated steatotic liver disease: In this population, HISI was approximately 50% lower in the presence of NAFLD independently of glucose tolerance, whereas the suppression of HGP during a low-dose insulin clamp (10 mU/m2 BSA/min) was more impaired in NAFLD individuals with prediabetes/diabetes (−44%) compared with individuals without NAFLD (−61%).